LL
| Investor | Type | Est. change | Change | Δ Own | Date | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Norges
· Exited
−$12.2B
Change
−12.1M
Δ Own
−100.0%
Date
Q1 2026
|
Norges | Exited· Q1 2026 | −$12.2B | −12.1M | −100.0% | Q1 2026 | |||||
|
J. Stern & Co. LLP
· Reduced
−$4.1B
Change
−4.0M
Date
Q1 2026
|
J. Stern & Co. LLP | Reduced· Q1 2026 | −$4.1B | −4.0M | – | Q1 2026 | |||||
|
Capital International Investors
· Reduced
−$3.8B
Change
−3.8M
Date
Q1 2026
|
Capital International Investors | Reduced· Q1 2026 | −$3.8B | −3.8M | – | Q1 2026 | |||||
|
State Farm Mutual Automobile Insurance Co
· Reduced
−$1.7B
Change
−1.7M
Date
Q1 2026
|
State Farm Mutual Automobile Insurance Co | Reduced· Q1 2026 | −$1.7B | −1.7M | – | Q1 2026 | |||||
|
Fifth Third Bancorp
· Added
+$1.5B
Change
+1.5M
Date
Q1 2026
|
Fifth Third Bancorp | Added· Q1 2026 | +$1.5B | +1.5M | – | Q1 2026 | |||||
|
Assenagon Asset Management S.A.
· Added
+$1.2B
Change
+1.2M
Date
Q1 2026
|
Assenagon Asset Management S.A. | Added· Q1 2026 | +$1.2B | +1.2M | – | Q1 2026 | |||||
|
Diamant Asset Management, Inc.
· Added
+$1.1B
Change
+1.1M
Date
Q1 2026
|
Diamant Asset Management, Inc. | Added· Q1 2026 | +$1.1B | +1.1M | – | Q1 2026 | |||||
|
T. Rowe Price Associates
· Reduced
−$931M
Change
−918K
Date
Q1 2026
|
T. Rowe Price Associates | Reduced· Q1 2026 | −$931M | −918K | – | Q1 2026 | |||||
|
Victory Capital Management Inc
· Reduced
−$828M
Change
−817K
Date
Q1 2026
|
Victory Capital Management Inc | Reduced· Q1 2026 | −$828M | −817K | – | Q1 2026 | |||||
|
CIBC Bancorp USA Inc.
· Added
+$806M
Change
+795K
Date
Q1 2026
|
CIBC Bancorp USA Inc. | Added· Q1 2026 | +$806M | +795K | – | Q1 2026 | |||||
|
Schroder Investment Management Group
· Reduced
−$790M
Change
−779K
Date
Q1 2026
|
Schroder Investment Management Group | Reduced· Q1 2026 | −$790M | −779K | – | Q1 2026 | |||||
|
JPMorgan Chase & Co
· Added
+$710M
Change
+701K
Date
Q1 2026
|
JPMorgan Chase & Co | Added· Q1 2026 | +$710M | +701K | – | Q1 2026 | |||||
|
Marshall Wace, LLP
· Reduced
−$641M
Change
−632K
Date
Q1 2026
|
Marshall Wace, LLP | Reduced· Q1 2026 | −$641M | −632K | – | Q1 2026 | |||||
|
FMR LLC
· Added
+$628M
Change
+619K
Δ Own
+2.4%
Date
Q1 2026
|
FMR LLC | Added· Q1 2026 | +$628M | +619K | +2.4% | Q1 2026 | |||||
|
Capital World Investors
· Added
+$598M
Change
+590K
Date
Q1 2026
|
Capital World Investors | Added· Q1 2026 | +$598M | +590K | – | Q1 2026 | |||||
| Insider | Title | Type | Price | Qty | Value | Owned | ΔOwn | Trade date | Filed date | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sulzberger Gabrielle
· Director
Grant (A)
$5K
|
Sulzberger Gabrielle | Director | Grant (A) | $1,146.90 | 4 | $5K | 3K | +0.1% | Jul 20, 2026 | Jul 21, 2026 | |||||||||
|
Luciano Juan R.
· Director
Grant (A)
$16K
|
Luciano Juan R. | Director | Grant (A) | $1,146.90 | 14 | $16K | 17K | +0.1% | Jul 20, 2026 | Jul 21, 2026 | |||||||||
|
Fyrwald J. Erik
· Director
Grant (A)
$10K
|
Fyrwald J. Erik | Director | Grant (A) | $1,146.90 | 9 | $10K | 75K | 0.0% | Jul 20, 2026 | Jul 21, 2026 | |||||||||
|
Alvarez Ralph
· Director
Grant (A)
$12K
|
Alvarez Ralph | Director | Grant (A) | $1,146.90 | 11 | $12K | 56K | 0.0% | Jul 20, 2026 | Jul 21, 2026 | |||||||||
|
Sulzberger Gabrielle
· Director
Grant (A)
$5K
|
Sulzberger Gabrielle | Director | Grant (A) | $1,129.35 | 4 | $5K | 3K | – | Jun 15, 2026 | Jun 16, 2026 | |||||||||
|
Luciano Juan R.
· Director
Grant (A)
$16K
|
Luciano Juan R. | Director | Grant (A) | $1,129.35 | 14 | $16K | 17K | – | Jun 15, 2026 | Jun 16, 2026 | |||||||||
|
Fyrwald J. Erik
· Director
Grant (A)
$10K
|
Fyrwald J. Erik | Director | Grant (A) | $1,129.35 | 9 | $10K | 75K | – | Jun 15, 2026 | Jun 16, 2026 | |||||||||
|
Alvarez Ralph
· Director
Grant (A)
$12K
|
Alvarez Ralph | Director | Grant (A) | $1,129.35 | 11 | $12K | 56K | – | Jun 15, 2026 | Jun 16, 2026 | |||||||||
|
Yuffa Ilya
· Officer
Sell
−$2.9M
|
Yuffa Ilya | Officer | Sell | $1,150.77 | −2K | −$2.9M | 30K | – | Jun 10, 2026 | Jun 11, 2026 | |||||||||
|
Sulzberger Gabrielle
· Director
Grant (A)
$5K
|
Sulzberger Gabrielle | Director | Grant (A) | $988.09 | 5 | $5K | 3K | – | May 18, 2026 | May 19, 2026 | |||||||||
|
Luciano Juan R.
· Director
Grant (A)
$16K
|
Luciano Juan R. | Director | Grant (A) | $988.09 | 16 | $16K | 17K | – | May 18, 2026 | May 19, 2026 | |||||||||
|
Fyrwald J. Erik
· Director
Grant (A)
$10K
|
Fyrwald J. Erik | Director | Grant (A) | $988.09 | 10 | $10K | 75K | – | May 18, 2026 | May 19, 2026 | |||||||||
|
Alvarez Ralph
· Director
Grant (A)
$12K
|
Alvarez Ralph | Director | Grant (A) | $988.09 | 13 | $12K | 56K | – | May 18, 2026 | May 19, 2026 | |||||||||
|
Lilly Endowment Inc
· Other
2 operations
−$16M
|
Lilly Endowment Inc | Other | 2 operations | $995.23–$996.18 | −16K | −$16M | 91.9M | – | May 6, 2026 | May 7, 2026 | |||||||||
|
Sulzberger Gabrielle
· Director
Grant (A)
$5K
|
Sulzberger Gabrielle | Director | Grant (A) | $919.90 | 5 | $5K | 3K | – | Apr 20, 2026 | Apr 21, 2026 | |||||||||
4,074 reporting institutions disclosed LLY position changes in the Q1 2026 snapshot.
For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.
An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.
Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.
Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.
A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.